Bioscience Archives

Helios Scholars at TGen featured at symposium

bioscience

The 45 interns in the 2014 Helios Scholars at TGen summer internship program graduated today, following a daylong scientific symposium at the Sheraton Phoenix Downtown Hotel. Arizona’s future leaders in biology and medicine worked for eight weeks in one of the nation’s premier scientific internship programs, sponsored by the Helios Education Foundation in partnership with… Read More →

TGen study provides new insights on HIV

Hiv+Aids+xgold+2012

A new study led by the Translational Genomics Research Institute (TGen) provides insights into the interplay among bacteria, viruses and the immune system during HIV infection. Currently, doctors measure HIV-positive men’s infectivity — their potential to infect others — based on their blood viral load. However, some men produce large amounts of virus in their… Read More →

Banner Alzheimer’s Institute partners with Novartis

alzheimers

Researchers from the Banner Alzheimer’s Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs—an active immunotherapy and an oral medication—can prevent or delay the emergence of symptoms of Alzheimer’s in people at particularly high risk for developing the disease at older ages. The five-year… Read More →

TGen study finds origin of lung fungus

medical.research

Cryptococcus gattii, a virulent fungus that has invaded the Pacific Northwest is highly adaptive and warrants global “public health vigilance,” according to a study by an international team led by the Translational Genomics Research Institute (TGen). C. gattii, which likely originated in Brazil, is responsible for dozens of deaths in recent years since it was… Read More →

UA Shows Curcumin Effect on Colon Cancer

cancer

A team of researchers led by the University of Arizona Steele Children’s Research Center discovered that curcumin—the bioactive molecule derived from the spice turmeric—blocks the protein cortactin in colon cancer. Cortactin, a protein essential for cell movement, frequently is overexpressed in cancer, thus facilitating cancer cell metastasis to other organs in the body. Colon cancer… Read More →

Innovators get boost from Arizona Commerce Authority

Staying Innovative as a One Man Operation

The Arizona Commerce Authority (ACA) has selected 18 recipients for AZ Fast Grant, a highly competitive grant program that provides qualified Arizona-based, early stage technology companies with intensive training and technical assistance to help them commercialize their innovations, grow their businesses and create quality jobs. “Early stage companies play a key role in developing innovations… Read More →

TGen teams up with Ceres Nanosciences

bioscience

The Translational Genomics Research Institute (TGen) and Ceres Nanosciences, Inc. (Ceres) today announced a development collaboration to benefit patients with cancer, infectious diseases, and other life-threatening illnesses. TGen, at the heart of Phoenix’s Biomedical Campus, is recognized as a pioneer in studying genomics, or DNA, to uncover the underlying molecular causes of disease, as well… Read More →

TGen, SHC begin clinical trial for anti-tumor drug

medical.research

The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, especially those with brain tumors and gallbladder bile duct cancer. “AG-120 is designed specifically for those patients who carry the IDH1… Read More →

ASU biogeochemist among 15 top scientist-educators

Ariel Anbar and ASU graduate student Yun Duan inspect a sample of 2.5 billion-year-old seafloor.

Biogeochemist Ariel Anbar has been selected as Arizona State University’s first Howard Hughes Medical Institute (HHMI) Professor. This distinguished honor recognizes Anbar’s pioneering research and teaching. He is one of 15 professors from 13 universities whose appointments were announced by the Maryland-based biomedical research institute on June 30. The appointment includes a five-year $1 million… Read More →

Maricopa Community Colleges strengthen STEM educaton

technical education career training looking at petri dish

As part of the State’s FY 2015 budget, the Maricopa Community Colleges received $1.4 million to bolster educational efforts in Science, Technology, Engineering and Math (STEM) and Workforce areas. This additional funding is the first State appropriation for Maricopa in areas of the STEM and Workforce since 2009. The criteria used to determine the allocation… Read More →

Merz acquires Mesa-based medical company Ulthera

Matt Likens - AZ Business Magazine January/February 2012

Merz and Ulthera, Inc. today announced that they have entered a definitive merger agreement, pursuant to which Merz will acquire global medical device company Ulthera, a deal which will accelerate Merz’s growth in the aesthetics area and expand the company’s portfolio of treatment options in facial aesthetics. Merz and Ulthera have entered a definitive merger… Read More →

Arizona bioscience industry producing ‘aha’ moments

bioscience

AZBio Expo 2014 had “aha moments” at every turn. With over 250 entrepreneurs, innovators, business leaders, legislators, scientists and researchers in attendance, the energy was sizzling and the outlook endless. Here are just a few of the event highlights, appropriately, A to Z: A – Access to Capital is the key. No money. No honey.… Read More →

TGen and NAU celebrate 5-year research pact

stem.cell

Northern Arizona University (NAU) and the Translational Genomics Research Institute (TGen) announced a five-year agreement to promote innovation and quality research benefiting Arizona. The NAU-TGen Memorandum of Understanding (MOU) implements the allocation of state funding as directed by Governor Jan Brewer and the Arizona Legislature, and reaffirms the commitment of both institutions toward quality research,… Read More →

RCT Ventures Announces MedTech Innovator Winner

health.innovation

RCT Ventures, an early-stage biomedical investment program of Tucson-based Research Corporation Technologies Inc., announced that Fibralign Corporation is the winner of the 2014 MedTech Innovator competition held during the 22nd Annual Medical Device Conference, hosted by law firm Wilson Sonsini Goodrich & Rosati (WSGR). As the first place winner, Fibralign Corporation won prizes valued at… Read More →